FIELD: medicine; pharmacology.
SUBSTANCE: sterile aripiprazole compound for injections with controllable elution in the form of sterile suspension provides aripiprazole release after an injection within at least one week, including: (a) aripiprazole which has the average size of particles approximately from 1 to 10 micron, (b) aripiprazole carrier, and (c) water for injections, and the specified structure for injections contains aripiprazole in amount from approximately 1% to 40% wt in relation to the total amount of the specified sterile compound for injections.
EFFECT: increase of adaptable ability of patients and decrease in frequency of relapses at schizophrenia treatment.
27 cl, 2 tbl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF OBTAINING ARIPIPRAZOLE SUSPENSION AND LYOPHILYSED COMPOSITION | 2008 |
|
RU2483711C2 |
| ARIPIPRAZOLE PRODRUG COMPOSITIONS | 2015 |
|
RU2817019C2 |
| MICROSPHERES HAVING NUCLEUS/COATING STRUCTURE | 2008 |
|
RU2485941C2 |
| ARIPIPRAZOLE PRODRUG COMPOSITIONS | 2015 |
|
RU2705376C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING WATER-INSOLUBLE ANTIPSYCHOTIC AGENT AND SORBITAN ESTERS | 2012 |
|
RU2627469C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING WATER-INSOLUBLE ANTIPSYCHOTIC DRUG AND SORBITAN ESTERS | 2012 |
|
RU2757859C2 |
| METHOD OF OBTAINING ACTIVE PHARMACEUTICAL SUBSTANCE, PRESENTING AMINODIHYDROPHTHALAZINEDIONE OF SODIUM | 2017 |
|
RU2673452C1 |
| LOW HYGROSCOPICITY ARYPYPRAZOLE MEDICINAL AGENT AND METHODS FOR ITS PREPARING | 2002 |
|
RU2259366C2 |
| MEDICINAL AGENTS WITH CONTROLLED RELEASE BASED ON BLOCK-COPOLYMERS | 2006 |
|
RU2409348C2 |
| COMPOUND ON BASIS OF ARIPIPRAZOLE COMPLEX | 2003 |
|
RU2342931C2 |
